EP0850316A4 - Cryptophycins from aberrant biosynthesis - Google Patents

Cryptophycins from aberrant biosynthesis

Info

Publication number
EP0850316A4
EP0850316A4 EP96932217A EP96932217A EP0850316A4 EP 0850316 A4 EP0850316 A4 EP 0850316A4 EP 96932217 A EP96932217 A EP 96932217A EP 96932217 A EP96932217 A EP 96932217A EP 0850316 A4 EP0850316 A4 EP 0850316A4
Authority
EP
European Patent Office
Prior art keywords
cryptophycins
aberrant
biosynthesis
aberrant biosynthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96932217A
Other languages
German (de)
French (fr)
Other versions
EP0850316A1 (en
Inventor
Richard E Moore
Thomas K Hemscheidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaii
Wayne State University
Original Assignee
University of Hawaii
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaii, Wayne State University filed Critical University of Hawaii
Publication of EP0850316A1 publication Critical patent/EP0850316A1/en
Publication of EP0850316A4 publication Critical patent/EP0850316A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
EP96932217A 1995-08-30 1996-08-30 Cryptophycins from aberrant biosynthesis Withdrawn EP0850316A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US293595P 1995-08-30 1995-08-30
US2935 1995-08-30
PCT/US1996/014670 WO1997008334A1 (en) 1995-08-30 1996-08-30 Cryptophycins from aberrant biosynthesis

Publications (2)

Publication Number Publication Date
EP0850316A1 EP0850316A1 (en) 1998-07-01
EP0850316A4 true EP0850316A4 (en) 2000-08-23

Family

ID=21703268

Family Applications (2)

Application Number Title Priority Date Filing Date
EP96932217A Withdrawn EP0850316A4 (en) 1995-08-30 1996-08-30 Cryptophycins from aberrant biosynthesis
EP96929780A Withdrawn EP0850057A4 (en) 1995-08-30 1996-08-30 Pharmaceutical compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP96929780A Withdrawn EP0850057A4 (en) 1995-08-30 1996-08-30 Pharmaceutical compounds

Country Status (6)

Country Link
EP (2) EP0850316A4 (en)
JP (2) JP2000507805A (en)
AU (2) AU6904896A (en)
BR (1) BR9610214A (en)
CA (2) CA2230540A1 (en)
WO (2) WO1997007798A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007798A1 (en) * 1995-08-30 1997-03-06 Eli Lilly And Company Pharmaceutical compounds
JP2000502351A (en) * 1995-12-22 2000-02-29 イーライ・リリー・アンド・カンパニー Pharmaceutical compounds
ES2267149T3 (en) * 1996-08-30 2007-03-01 University Of Hawaii NEW CRYPTOPHINE DERIVATIVES AS ANTINEOPLASIC AGENTS.
JP2001500484A (en) * 1996-08-30 2001-01-16 イーライ・リリー・アンド・カンパニー Method for producing pharmaceutical compounds
AU4330097A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Pharmaceutical compounds
US6680311B1 (en) 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
IL128643A0 (en) * 1996-09-06 2000-01-31 Lilly Co Eli Process to prepare pharmaceutical compounds
US6020512A (en) * 1996-09-06 2000-02-01 Eli Lilly And Company Process and novel intermediates
NZ336918A (en) * 1997-02-26 2001-11-30 Lilly Co Eli Selective epoxidation process for preparing pharmaceutical compounds comprising Cryptophycin 52
WO1998038178A1 (en) * 1997-02-26 1998-09-03 Eli Lilly And Company Tripeptide and tetrapeptide pharmaceutical compounds
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
EP0870501A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
US6180679B1 (en) * 1998-04-07 2001-01-30 Eli Lilly And Company Method for treating fungal infections
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2003077906A1 (en) * 2002-03-18 2003-09-25 Nihon University Cyclic etheramine derivatives as medicaments for malignant tumors
US7229814B2 (en) 2004-05-05 2007-06-12 Regents Of The University Of Minnesota Nucleic acids and polypeptides involved in the production of cryptophycin
JPWO2007000994A1 (en) * 2005-06-28 2009-01-22 中外製薬株式会社 Method for producing compound having anti-HCV action
CN103724290B (en) * 2013-11-15 2015-04-29 浙江大学 Cyclopeptide compound clavatustide A as well as producing strain, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
GB2220657A (en) * 1988-07-15 1990-01-17 Merck & Co Inc Antifungal fermentation product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
PL185949B1 (en) * 1995-03-07 2003-09-30 Univ Hawaii Novel synthetic cryptophycines
WO1997007798A1 (en) * 1995-08-30 1997-03-06 Eli Lilly And Company Pharmaceutical compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2220657A (en) * 1988-07-15 1990-01-17 Merck & Co Inc Antifungal fermentation product
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
C.D. SMITH ET AL., CANCER RES., vol. 54, no. 14, 1994, pages 3779 - 3784 *
CHEMICAL ABSTRACTS, vol. 114, no. 2, 14 January 1991, Columbus, Ohio, US; abstract no. 12039, XP002140923 *
CHEMICAL ABSTRACTS, vol. 121, no. 9, 29 August 1994, Columbus, Ohio, US; abstract no. 99272, XP002140925 *
CHEMICAL ABSTRACTS, vol. 123, no. 13, 25 September 1995, Columbus, Ohio, US; abstract no. 164737, XP002140924 *
G. TRIMURTULU ET AL., TENNEN YUKI KAGOBUTSU TORONKAI KOEN YOSHISHU, vol. 36th, 1994, pages 744 - 751 *
R.E. SCHWARTZ ET AL., J. IND. MICROBIOL., vol. 5, no. 2-3, 1990, pages 113 - 123 *
See also references of WO9708334A1 *

Also Published As

Publication number Publication date
EP0850057A1 (en) 1998-07-01
JP2000501067A (en) 2000-02-02
BR9610214A (en) 1999-06-15
WO1997007798A1 (en) 1997-03-06
AU7109096A (en) 1997-03-19
AU709828B2 (en) 1999-09-09
CA2246117A1 (en) 1997-03-06
WO1997008334A1 (en) 1997-03-06
CA2230540A1 (en) 1997-03-06
AU6904896A (en) 1997-03-19
EP0850316A1 (en) 1998-07-01
JP2000507805A (en) 2000-06-27
EP0850057A4 (en) 2001-04-11

Similar Documents

Publication Publication Date Title
EP0850316A4 (en) Cryptophycins from aberrant biosynthesis
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
AP9701069A0 (en) New cryptophycins from synthesis
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
EP0836382A4 (en) New cryptophycins
GB9523920D0 (en) Bearings
DE69623258D1 (en) Copolyetherester
GB9510161D0 (en) Shower tray
GB9619282D0 (en) Insert
GB9510458D0 (en) Shower tray
GB9510563D0 (en) Well inhibition
GB2308509B (en) Services-connections for trailer-vehicles
GB2298904B (en) Bearings
IL113922A0 (en) Seizing instrument
GB9508715D0 (en) Cabinet
GB2308393B (en) Windshelter for sun-bathing
ZA963210B (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles.
ZA961745B (en) New cryptophycins from synthesis.
DE69517202D1 (en) Stock
GB2298174B (en) Services-connections for trailer-vehicles
PL311364A1 (en) Insert
AU127609S (en) Organizer
GB9518808D0 (en) Insert
GB9518786D0 (en) Insert

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12P 21/04 A, 7C 12P 21/02 B, 7C 07D 273/00 B, 7C 07D 413/06 B, 7C 07D 413/14 B, 7C 07D 413/06 J, 7C 07D 303:00 J, 7C 07D 273:00 J

A4 Supplementary search report drawn up and despatched

Effective date: 20000712

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20010417

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010828